Zydus receives final approval from US FDA for Empagliflozin and Metformin Hydrochloride Tablets Read more
US FDA approves Bristol Myers Squibb’s CAR-T cell therapy Breyanzi for relapsed large B-cell lymphoma after one prior therapy Read more
Zydus Lifesciences receives final approval from US FDA for Adapalene and Benzoyl Peroxide Topical Gel Read more